P
Primmune Therapeutics
Verified company Profile managed by Bizz IdPrimmune
Estados Unidos
11-50 employees
2017
Description
Primmune Therapeutics is a clinical-stage biotech founded in 2017 in San Diego, California, developing systemic oral cancer immunotherapies. Lead program PRTX007 is an orally administered TLR7 agonist that activates plasmacytoid dendritic cells. Has raised $47M in Series B funding.